Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
0.345
+0.021 (6.31%)
At close: Jan 3, 2025, 4:00 PM
0.349
+0.003 (0.90%)
After-hours: Jan 3, 2025, 7:59 PM EST
Cellectar Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 3, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 14 | 34 | 16 | 41 | 94 | 21 | |
| Market Cap Growth | 192.98% | 112.09% | -60.44% | -57.05% | 346.77% | 186.68% | |
| Enterprise Value | -19 | 35 | -0 | 2 | 77 | 10 | |
| Last Close Price | 0.35 | 2.77 | 1.71 | 6.64 | 20.80 | 22.50 | |
| PB Ratio | 9.04 | -2.47 | 1.68 | 1.23 | 1.72 | 2.33 | |
| P/TBV Ratio | 49.51 | - | 1.97 | 1.28 | 2.72 | 2.67 | |
| Debt / Equity Ratio | 0.03 | -0.04 | 0.06 | 0.01 | 0.01 | 0.06 | |
| Quick Ratio | 1.69 | 0.38 | 1.73 | 8.95 | 16.04 | 3.83 | |
| Current Ratio | 1.77 | 0.41 | 1.78 | 9.16 | 16.26 | 4.11 | |
| Return on Equity (ROE) | -474.63% | - | -149.33% | -54.92% | -47.28% | -126.28% | |
| Return on Assets (ROA) | -109.57% | -144.66% | -61.26% | -31.47% | -26.95% | -64.91% | |
| Return on Capital (ROIC) | -290.49% | - | -82.82% | -34.06% | -29.49% | -77.56% | |
| Earnings Yield | -351.52% | -125.65% | -198.10% | -59.46% | -15.98% | -66.66% | |
| FCF Yield | -326.74% | -97.66% | -158.57% | -55.98% | -14.82% | -55.43% | |
| Buyback Yield / Dilution | -173.55% | -73.22% | -27.09% | -180.20% | -158.14% | -159.12% | |
| Total Shareholder Return | -173.55% | -73.22% | -27.09% | -180.20% | -158.14% | -159.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.